AU2016335866B2 - Crosslinked particles - Google Patents
Crosslinked particles Download PDFInfo
- Publication number
- AU2016335866B2 AU2016335866B2 AU2016335866A AU2016335866A AU2016335866B2 AU 2016335866 B2 AU2016335866 B2 AU 2016335866B2 AU 2016335866 A AU2016335866 A AU 2016335866A AU 2016335866 A AU2016335866 A AU 2016335866A AU 2016335866 B2 AU2016335866 B2 AU 2016335866B2
- Authority
- AU
- Australia
- Prior art keywords
- crosslinked
- particles
- independently
- occurrence
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Materials For Medical Uses (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polyesters Or Polycarbonates (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Epoxy Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021202965A AU2021202965B2 (en) | 2015-10-09 | 2021-05-10 | Crosslinked particles |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562239758P | 2015-10-09 | 2015-10-09 | |
| US62/239,758 | 2015-10-09 | ||
| US201662281631P | 2016-01-21 | 2016-01-21 | |
| US62/281,631 | 2016-01-21 | ||
| US201662313013P | 2016-03-24 | 2016-03-24 | |
| US62/313,013 | 2016-03-24 | ||
| PCT/US2016/056135 WO2017062871A1 (en) | 2015-10-09 | 2016-10-07 | Crosslinked particles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021202965A Division AU2021202965B2 (en) | 2015-10-09 | 2021-05-10 | Crosslinked particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2016335866A1 AU2016335866A1 (en) | 2018-05-17 |
| AU2016335866B2 true AU2016335866B2 (en) | 2021-02-11 |
Family
ID=58488602
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016335866A Active AU2016335866B2 (en) | 2015-10-09 | 2016-10-07 | Crosslinked particles |
| AU2021202965A Active AU2021202965B2 (en) | 2015-10-09 | 2021-05-10 | Crosslinked particles |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021202965A Active AU2021202965B2 (en) | 2015-10-09 | 2021-05-10 | Crosslinked particles |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10258578B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4019575B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP6852079B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109843996B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2016335866B2 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2906596T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017062871A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4019575B1 (en) | 2015-10-09 | 2023-12-06 | Le Dévédec, Frantz | Crosslinked particles |
| US11905377B2 (en) | 2019-01-17 | 2024-02-20 | Pendant Biosciences, Inc. | Factors controlling drug release in cross-linked poly(valerolactone) based matrices |
| WO2021127623A1 (en) * | 2019-12-19 | 2021-06-24 | Pendant Biosciences, Inc. | Crosslinked pla-based copolymers |
| US20250215215A1 (en) * | 2022-03-29 | 2025-07-03 | Kaneka Corporation | Thermoplastic resin composition |
| EP4506395A4 (en) * | 2022-03-29 | 2026-04-15 | Kaneka Corp | CROSS-CUT RESIN PARTICLES AND THEIR PRODUCTION PROCESS |
| US20250388748A1 (en) * | 2022-03-29 | 2025-12-25 | Kaneka Corporation | Thermoplastic resin composition |
| JPWO2025075122A1 (cg-RX-API-DMAC7.html) * | 2023-10-04 | 2025-04-10 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130142733A1 (en) * | 2007-11-05 | 2013-06-06 | Vanderbilt University | Multifunctional degradable nanoparticles with control over size and functionalities |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003219922B2 (en) * | 2002-02-27 | 2009-09-10 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
| US6800663B2 (en) * | 2002-10-18 | 2004-10-05 | Alkermes Controlled Therapeutics Inc. Ii, | Crosslinked hydrogel copolymers |
| US8808681B2 (en) | 2006-06-05 | 2014-08-19 | Massachusetts Institute Of Technology | Crosslinked, degradable polymers and uses thereof |
| CN100546661C (zh) * | 2006-12-01 | 2009-10-07 | 华南理工大学 | 一种原位成孔自固化磷酸钙复合组织工程支架的制备方法 |
| US20110274620A1 (en) * | 2007-11-05 | 2011-11-10 | Harth Eva M | Multifunctional degradable nanoparticles with control over size and functionalities |
| DK2209496T3 (da) | 2007-11-05 | 2019-08-05 | Univ Vanderbilt | Multifunktionelle nedbrydelige nanopartikler med kontrol over størrelse og funktioner |
| CN103003260A (zh) | 2009-12-21 | 2013-03-27 | 赢创德固赛有限公司 | 用于制备包含不饱和官能团的环酯的方法和由其制备的聚酯 |
| WO2013169938A2 (en) * | 2012-05-08 | 2013-11-14 | Vanderbilt University | Polycarbonate containing compounds and methods related thereto |
| ITTO20130431A1 (it) * | 2013-05-28 | 2014-11-29 | Fond Istituto Italiano Di Tecnologia | Copolimero e nanoparticelle da esso ottenute per la veicolazione di un farmaco |
| WO2016174116A1 (en) | 2015-04-27 | 2016-11-03 | Eggplant S.R.L. | Polyester composition and method for producing the same |
| EP4019575B1 (en) | 2015-10-09 | 2023-12-06 | Le Dévédec, Frantz | Crosslinked particles |
-
2016
- 2016-10-07 EP EP21211254.4A patent/EP4019575B1/en active Active
- 2016-10-07 ES ES16854494T patent/ES2906596T3/es active Active
- 2016-10-07 CN CN201680072252.2A patent/CN109843996B/zh active Active
- 2016-10-07 US US15/289,005 patent/US10258578B2/en active Active
- 2016-10-07 ES ES21211254T patent/ES2973475T3/es active Active
- 2016-10-07 AU AU2016335866A patent/AU2016335866B2/en active Active
- 2016-10-07 WO PCT/US2016/056135 patent/WO2017062871A1/en not_active Ceased
- 2016-10-07 JP JP2018538068A patent/JP6852079B2/ja active Active
- 2016-10-07 EP EP16854494.8A patent/EP3359591B1/en active Active
-
2019
- 2019-02-27 US US16/287,690 patent/US11426356B2/en active Active
-
2021
- 2021-03-10 JP JP2021037974A patent/JP7104198B2/ja active Active
- 2021-05-10 AU AU2021202965A patent/AU2021202965B2/en active Active
-
2022
- 2022-07-07 JP JP2022109826A patent/JP7500659B2/ja active Active
- 2022-07-22 US US17/871,339 patent/US20230190664A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130142733A1 (en) * | 2007-11-05 | 2013-06-06 | Vanderbilt University | Multifunctional degradable nanoparticles with control over size and functionalities |
Non-Patent Citations (1)
| Title |
|---|
| ZOU, J et al., "Clicking Well‐Defined Biodegradable Nanoparticles and Nanocapsules by UV‐Induced Thiol‐Ene Cross‐Linking in Transparent Miniemulsions", Advanced Materials, 2011, vol. 23, pages 4274-4277 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20190262274A1 (en) | 2019-08-29 |
| CA3001329A1 (en) | 2017-04-13 |
| EP3359591A1 (en) | 2018-08-15 |
| JP7500659B2 (ja) | 2024-06-17 |
| AU2016335866A1 (en) | 2018-05-17 |
| US20170100343A1 (en) | 2017-04-13 |
| CN109843996A (zh) | 2019-06-04 |
| EP3359591A4 (en) | 2019-05-29 |
| EP4019575A1 (en) | 2022-06-29 |
| EP4019575B1 (en) | 2023-12-06 |
| ES2973475T3 (es) | 2024-06-20 |
| EP3359591B1 (en) | 2021-12-01 |
| JP2021102622A (ja) | 2021-07-15 |
| CN109843996B (zh) | 2022-09-06 |
| WO2017062871A1 (en) | 2017-04-13 |
| JP2019500403A (ja) | 2019-01-10 |
| US10258578B2 (en) | 2019-04-16 |
| AU2021202965A1 (en) | 2021-06-03 |
| JP6852079B2 (ja) | 2021-03-31 |
| JP2022130727A (ja) | 2022-09-06 |
| JP7104198B2 (ja) | 2022-07-20 |
| US11426356B2 (en) | 2022-08-30 |
| US20230190664A1 (en) | 2023-06-22 |
| ES2906596T3 (es) | 2022-04-19 |
| AU2021202965B2 (en) | 2023-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021202965B2 (en) | Crosslinked particles | |
| US10245244B2 (en) | Pharmaceutical formulations for the treatment of pulmonary arterial hypertension | |
| WO2019108030A1 (ko) | 안정성 및 저장 안정성이 향상된 생분해성 미립구의 제조방법 | |
| Wischke et al. | Controlled drug release from biodegradable shape-memory polymers | |
| JP2023511978A (ja) | 外膜又は外膜周囲の神経アブレーションのための徐放性マトリックス及びその使用 | |
| Bertram et al. | Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF | |
| Sandker et al. | Degradation, intra-articular retention and biocompatibility of monospheres composed of [PDLLA-PEG-PDLLA]-b-PLLA multi-block copolymers | |
| Amani et al. | Preparation and pulsatile release evaluation of teriparatide-loaded multilayer implant composed of polyanhydride-hydrogel layers using spin coating for the treatment of osteoporosis | |
| JP2019500403A5 (cg-RX-API-DMAC7.html) | ||
| JP2011518812A (ja) | チオエステル結合を有するポリマーを含む粒子 | |
| CN110051652A (zh) | Plga/fk506载药纳米微球及其制备方法和应用 | |
| Buwalda et al. | In situ forming stereocomplexed and post-photocrosslinked acrylated star poly (ethylene glycol)-poly (lactide) hydrogels | |
| WO2024173668A1 (en) | Biodegradable microparticles for sustained drug delivery, methods of preparation and use thereof | |
| HK40009686A (en) | Crosslinked particles | |
| HK40009686B (en) | Crosslinked particles | |
| US20190134202A1 (en) | Liquid Injectable Copolymer | |
| CN105193732A (zh) | 雷帕霉素纳米缓释微球及其制备方法 | |
| Marques et al. | PKPD of PLGA-PEG-PLGA Copolymeric Micelles | |
| CN119744167A (zh) | 含有药物和帕莫酸的缓释微球 | |
| KV et al. | Preparation of Poly-ε-Caprolactone Nanoparticles by Double Emulsion Solvent Evaporation Technique for Ocular Delivery |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |